Influence of single nucleotide polymorphisms in pri-miR-124-1 and STAT3 genes on gastric cancer susceptibility

References

• Chun N, Ford JM. Genetic testing by cancer site: stomach. Cancer J. 2012;18(4):355–363.
   PubMed Web of Science ®Google Scholar
• Gong J, Cao J, Liu G, et al. Function and mechanism of F-box proteins in gastric cancer. Int J Oncol. 2015;47(1):43–50.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
   PubMed Web of Science ®Google Scholar
• Sadjadi A, Malekzadeh R, Derakhshan MH, et al. Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran. Int J Cancer. 2003;107(1):113–118.
   PubMed Web of Science ®Google Scholar
• Hu B, El Hajj N, Sittler S, et al. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3(3):251–261.
   PubMedGoogle Scholar
• Quintas-Cardama A, Verstovsek S. Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance. Clin Cancer Res. 2013;19(8):1933–1940.
   PubMed Web of Science ®Google Scholar
• O’Shea JJ, Holland SM, Staudt LM. JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med. 2013;368(2):161–170.
   PubMed Web of Science ®Google Scholar
• Walker SR, Xiang M, Frank DA. STAT3 activity and function in cancer: modulation by STAT5 and miR-146b. Cancers. 2014;6(2):958–968.
   PubMed Web of Science ®Google Scholar
• Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol. 2001;13(2):211–217.
   PubMed Web of Science ®Google Scholar
• Zhang HF, Lai R. STAT3 in cancer-friend or foe? Cancers. 2014;6(3):1408–1440.
   PubMed Web of Science ®Google Scholar
• Zhao J, Dong Y, Kang W, et al. Helicobacter pylori-induced STAT3 activation and signalling network in gastric cancer. Oncoscience. 2014;1(6):468–475.
   PubMedGoogle Scholar
• Siveen KS, Sikka S, Surana R, et al. Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. Biochim Biophys Acta. 2014;1845(2):136–154.
   PubMed Web of Science ®Google Scholar
• Jackson CB, Giraud AS. STAT3 as a prognostic marker in human gastric cancer. J Gastroenterol Hepatol. 2009;24(4):505–507.
   PubMed Web of Science ®Google Scholar
• Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425(6956):415–419.
   PubMed Web of Science ®Google Scholar
• Koukos G, Polytarchou C, Kaplan JL, et al. MicroRNA-124 regulates STAT3 expression and is down-regulated in colon tissues of pediatric patients with ulcerative colitis. Gastroenterology. 2013;145(4):842–52 e2.
   PubMed Web of Science ®Google Scholar
• Mullany LE, Wolff RK, Herrick JS, et al. SNP Regulation of microRNA expression and subsequent colon cancer risk. PLoS One. 2015;10(12):e0143894.
   PubMed Web of Science ®Google Scholar
• Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A. 2007;104(9):3300–3305.
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang X, Xiao J, et al. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations. PLoS One. 2014;9(6):e100055.
   PubMed Web of Science ®Google Scholar
• Gao XR, Wang HP, Zhang SL, et al. Pri-miR-124 rs531564 polymorphism and colorectal cancer risk. Sci Rep. 2015;5:14818.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhang J. miR-124 rs531564 polymorphism influences genetic susceptibility to cervical cancer. Int J Clin Exp Med. 2014;7(12):5847–5851.
   PubMed Web of Science ®Google Scholar
• Fang C, Zeng H, Li A, et al. Association of the pri-rs531564 polymorphism with cancer risk: A meta-analysis. Mol Clin Oncol. 2015;3(4):892–896.
   PubMed Web of Science ®Google Scholar
• Ying HQ, Peng HX, He BS, et al. MiR-608, pre-miR-124-1 and pre-miR26a-1 polymorphisms modify susceptibility and recurrence-free survival in surgically resected CRC individuals. Oncotarget. 2016;7(46):75865–75873.
   PubMedGoogle Scholar
• Wu D, Yang G, Zhang L, et al. Genome-wide association study combined with biological context can reveal more disease-related SNPs altering microRNA target seed sites. BMC Genomics. 2014;15:669.
   PubMed Web of Science ®Google Scholar
• Butterbach K, Beckmann L, de Sanjose S, et al. Association of JAK-STAT pathway related genes with lymphoma risk: results of a European case-control study (EpiLymph). Br J Haematol. 2011;153(3):318–333.
   PubMed Web of Science ®Google Scholar
• He F, Yang R, Li XY, et al. Single nucleotide polymorphisms of the NF-kappaB and STAT3 signaling pathway genes predict lung cancer prognosis in a Chinese Han population. Cancer Genet. 2015;208(6):310–318.
   PubMed Web of Science ®Google Scholar
• Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An Attempt at a Histo-Clinical Classification. Acta Pathol Microbiol Scand. 1965;64:31–49.
   Google Scholar
• Tong X, Wang X, Wang C, et al. Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3. Br J Biomed Sci. 2018;75(1):7–12.
   PubMed Web of Science ®Google Scholar
• Mashayekhi S, Saeidi Saedi H, Salehi Z, et al. Effects of miR-27a, miR-196a2 and miR-146a polymorphisms on the risk of breast cancer. Br J Biomed Sci. 2018;75(2):76–81.
   PubMed Web of Science ®Google Scholar
• Taniguchi K, Sugito N, Kumazaki M, et al. MicroRNA-124 inhibits cancer cell growth through PTB1/PKM1/PKM2 feedback cascade in colorectal cancer. Cancer Lett. 2015;363(1):17–27.
   PubMed Web of Science ®Google Scholar
• Li SL, Gao HL, Lv XK, et al. MicroRNA-124 inhibits cell invasion and epithelial-mesenchymal transition by directly repressing Snail2 in gastric cancer. Eur Rev Med Pharmacol Sci. 2017;21(15):3389–3396.
   PubMed Web of Science ®Google Scholar
• Qi L, Hu Y, Zhan Y, et al. A SNP site in pri-miR-124 changes mature miR-124 expression but no contribution to Alzheimer’s disease in a Mongolian population. Neurosci Lett. 2012;515(1):1–6.
   PubMed Web of Science ®Google Scholar
• Chuanyin L, Xiaona W, Zhiling Y, et al. The association between polymorphisms in microRNA genes and cervical cancer in a Chinese Han population. Oncotarget. 2017;8(50):87914–87927.
   PubMedGoogle Scholar
• Han ZB, Yang Z, Chi Y, et al. MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151. Cell Physiol Biochem. 2013;31(6):823–832.
   PubMed Web of Science ®Google Scholar
• Yamane K, Jinnin M, Etoh T, et al. Down-regulation of miR-124/-214 in cutaneous squamous cell carcinoma mediates abnormal cell proliferation via the induction of ERK. J Mol Med. 2013;91(1):69–81.
   PubMed Web of Science ®Google Scholar
• Yue P, Targeting TJ. STAT3 in cancer: how successful are we? Expert Opin Investig Drugs. 2009;18(1):45–56.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kunnumakkara AB, Harikumar KB, et al. Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci. 2009;1171:59–76.
   PubMed Web of Science ®Google Scholar
• Wang J, Chen R, Tang S, et al. Analysis of IL-6, STAT3 and HSPA1L gene polymorphisms in anti-tuberculosis drug-induced hepatitis in a nested case-control study. PLoS One. 2015;10(3):e0118862.
   PubMed Web of Science ®Google Scholar
• Messaoudi S, Hizem S, Al-Sulaiti MA, et al. Contribution of JAK2 and STAT3 variants to the genetic susceptibility of recurrent spontaneous miscarriage in a Tunisian population. Genet Test Mol Biomarkers. 2013;17(1):35–39.
   PubMed Web of Science ®Google Scholar
• Pirooz HJ, Jafari N, Rastegari M, et al. Functional SNP in microRNA-491-5p binding site of MMP9 3ʹ-UTR affects cancer susceptibility. J Cell Biochem. 2018;119:5126–5134.
   PubMed Web of Science ®Google Scholar
• Yadegari ZS, Akrami H, Hosseini SV, et al. miR-146a gene polymorphism and susceptibility to gastric cancer. Br J Biomed Sci. 2016;73(4):201–203.
   PubMed Web of Science ®Google Scholar